Use of barbiturates and benzodiazepines in treatment of epilepsy.
Barbiturates and benzodiazepines may be very effective in controlling seizures, especially status epilepticus. However, their chronic use may be associated with serious sedative-hypnotic effects that interfere with cognitive function and behavior. When utilized, patients must be carefully monitored to be certain that these side effects are not occurring.
D000328:Adult; D001463:Barbiturates / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002998:Clonazepam / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003009:Clorazepate Dipotassium / Q000627:therapeutic use; D003975:Diazepam / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008140:Lorazepam / Q000627:therapeutic use; D010634:Phenobarbital / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011324:Primidone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D001463:Barbiturates; D001569:Benzodiazepines; D011324:Primidone; D002998:Clonazepam; D003009:Clorazepate Dipotassium; D008140:Lorazepam; D003975:Diazepam; D010634:Phenobarbital